Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A murine model for hypertrophic cardiomyopathy

K L Vikstrom1, S M Factor, L A Leinwand

  • 1Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

Zeitschrift Fur Kardiologie
|January 1, 1995
PubMed
Summary

Familial hypertrophic cardiomyopathy (FHC) is a genetic heart disease. Transgenic mice expressing mutant myosin heavy chains develop FHC, providing a model for studying this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular pathology: A new journal for an old need.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Parasitic diseases of the heart I: Acute and chronic Chagas' disease.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Microfibrillar cardiomyopathy: An infiltrative heart disease resembling but distinct from cardiac amyloidosis.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Hypertrophic cardiomyopathy in pigs: quantitative pathologic features in 55 cases.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Transient loss of vision as the presenting symptom of papillary fibroelastoma of aortic valve.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Cardiomyopathy in a male with cystinosis.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Animal Models

Background:

  • Familial hypertrophic cardiomyopathy (FHC) is an autosomal dominant genetic heart disease and a leading cause of sudden death in young athletes.
  • Mutations in contractile proteins, such as cardiac myosin heavy chains, are implicated in FHC, suggesting it is a sarcomere disease.

Purpose of the Study:

  • To develop an animal model for familial hypertrophic cardiomyopathy (FHC).
  • To investigate the role of mutant cardiac myosin heavy chains in the pathogenesis of FHC.

Main Methods:

  • Generation of five lines of transgenic mice expressing a mutant cardiac myosin heavy chain in their hearts.
  • Histopathological analysis of mouse hearts to identify disease features.
  • Assessment of transgene expression and its correlation with cardiac pathology.

Main Results:

  • Transgenic mouse hearts exhibited histopathological features consistent with human FHC.
  • Enlarged left ventricles were observed in the hearts of mice expressing the mutant myosin.
  • The mutant protein acted in a dominant-negative manner, constituting 5-10% of total cardiac myosin.
  • Pathology was confined to the left ventricle despite transgene expression in all heart chambers.

Conclusions:

  • The developed transgenic mouse model effectively recapitulates key features of familial hypertrophic cardiomyopathy (FHC).
  • The findings suggest that left ventricular pathology in FHC may involve secondary responses to factors like hemodynamics.
  • This model provides a valuable tool for further research into FHC mechanisms and potential therapies.

Related Experiment Videos